WALTHAM, MA, Developer of treatments for diseases that affect mucosal tissues, announced that it raised $6.2M in additional equity financing from existing venture investors Lux Capital, Polaris Venture Partners, Third Rock Ventures, and Lighthouse Capital Partners.
Read More